Combination of mesenchymal stem cells and nicorandil: an emerging therapeutic challenge against COVID-19 infection-induced multiple organ dysfunction

The recent COronaVIrus Disease (COVID)-19 pandemic has placed an unprecedented burden on the drug development opportunity to prevent the onset of multi-organ failure. Emerging experimental reports have highlighted the beneficial effects of mesenchymal stem cell (MSC) administration against COVID-19....

Descripción completa

Detalles Bibliográficos
Autores principales: Safari, Anahid, Lionetti, Vicenzo, Razeghian-Jahromi, Iman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280613/
https://www.ncbi.nlm.nih.gov/pubmed/34266486
http://dx.doi.org/10.1186/s13287-021-02482-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280613/
https://www.ncbi.nlm.nih.gov/pubmed/34266486
http://dx.doi.org/10.1186/s13287-021-02482-8

Ejemplares similares